Parashar Umesh D, Burton Anthony, Lanata Claudio, Boschi-Pinto Cynthia, Shibuya Kenji, Steele Duncan, Birmingham Maureen, Glass Roger I
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
J Infect Dis. 2009 Nov 1;200 Suppl 1:S9-S15. doi: 10.1086/605025.
As new rotavirus vaccines are being introduced in immunization programs, global and national estimates of disease burden, especially rotavirus-associated mortality, are needed to assess the potential health benefits of vaccination and to monitor vaccine impact.
We identified 76 studies that were initiated after 1990, lasted at least 1 full year, and examined rotavirus among >100 children hospitalized with diarrhea. The studies were assigned to 5 groups (A-E) with use of World Health Organization classification of countries by child mortality and geography. For each group, the mean rotavirus detection rate was multiplied by diarrhea-related mortality figures from 2004 for countries in that group to yield estimates of rotavirus-associated mortality.
Overall, rotavirus accounted for 527,000 deaths (95% confidence interval, 475,000-580,000 deaths) annually or 29% of all deaths due to diarrhea among children <5 years of age. Twenty-three percent of deaths due to rotavirus disease occurred in India, and 6 countries (India, Nigeria, Congo, Ethiopia, China, and Pakistan) accounted for more than one-half of deaths due to rotavirus disease.
The high mortality associated with rotavirus disease underscores the need for targeted interventions, such as vaccines. To realize the full life-saving potential of vaccines, it will be vital to ensure that they reach children in countries with high mortality. These baseline figures will allow future assessment of vaccine impact on rotavirus-associated mortality.
随着新型轮状病毒疫苗被引入免疫规划,需要对疾病负担进行全球和国家层面的评估,尤其是轮状病毒相关死亡率,以评估疫苗接种的潜在健康益处并监测疫苗效果。
我们确定了76项于1990年后启动、持续至少一整年且对100多名腹泻住院儿童进行轮状病毒检测的研究。这些研究根据世界卫生组织按儿童死亡率和地理位置对国家的分类被分为5组(A - E)。对于每组,将该组各国的轮状病毒平均检出率乘以2004年腹泻相关死亡率数据,以得出轮状病毒相关死亡率的估计值。
总体而言,轮状病毒每年导致52.7万例死亡(95%置信区间为47.5万 - 58.0万例死亡),占5岁以下儿童腹泻所致所有死亡的29%。23%的轮状病毒疾病死亡发生在印度,6个国家(印度、尼日利亚、刚果、埃塞俄比亚、中国和巴基斯坦)占轮状病毒疾病死亡的一半以上。
轮状病毒疾病相关的高死亡率凸显了采取针对性干预措施(如疫苗)的必要性。为充分发挥疫苗的救命潜力,确保高死亡率国家的儿童能够接种疫苗至关重要。这些基线数据将有助于未来评估疫苗对轮状病毒相关死亡率的影响。